• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能增强的儿科患者抗菌药物的个体化应用:文献综述

Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.

作者信息

Xu Wei-Xin, Qu Qiang, Teng Xin-Qi, Zhuang Hai-Hui, Liu Si-Fan, Wang Ying, Qu Jian

机构信息

Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.

Institute of Clinical Pharmacy, Central South University, No.139 Middle Renmin Road, Changsha, 410011, People's Republic of China.

出版信息

Eur J Pediatr. 2024 Jan;183(1):51-60. doi: 10.1007/s00431-023-05272-x. Epub 2023 Oct 20.

DOI:10.1007/s00431-023-05272-x
PMID:37861791
Abstract

UNLABELLED

The effect of renal functional status on drug metabolism is a crucial consideration for clinicians when determining the appropriate dosage of medications to administer. In critically ill patients, there is often a significant increase in renal function, which leads to enhanced drug metabolism and potentially inadequate drug exposure. This phenomenon, known as augmented renal clearance (ARC), is commonly observed in pediatric critical care settings. The findings of the current study underscore the significant impact of ARC on the pharmacokinetics and pharmacodynamics of antimicrobial drugs in critically ill pediatric patients. Moreover, the study reveals a negative correlation between increased creatinine clearance and blood concentrations of antimicrobial drugs. The article provides a comprehensive review of ARC screening in pediatric patients, including its definition, risk factors, and clinical outcomes. Furthermore, it summarizes the dosages and dosing regimens of commonly used antibacterial and antiviral drugs for pediatric patients with ARC, and recommendations are made for dose and infusion considerations and the role of therapeutic drug monitoring.

CONCLUSION

ARC impacts antimicrobial drugs in pediatric patients.

WHAT IS KNOWN

• ARC is inextricably linked to the failure of antimicrobial therapy, recurrence of infection, and subtherapeutic concentrations of drugs.

WHAT IS NEW

• This study provides an updated overview of the influence of ARC on medication use and clinical outcomes in pediatric patients. • In this context, there are several recommendations for using antibiotics in pediatric patients with ARC: 1) increase the dose administered; 2) prolonged or continuous infusion administration; 3) use of TDM; and 4) use alternative drugs that do not undergo renal elimination.

摘要

未标注

肾功能状态对药物代谢的影响是临床医生在确定给药合适剂量时的关键考虑因素。在危重症患者中,肾功能通常会显著增强,这会导致药物代谢加快,进而可能使药物暴露不足。这种现象被称为肾清除率增加(ARC),在儿科重症监护环境中很常见。当前研究结果强调了ARC对危重症儿科患者抗菌药物药代动力学和药效学的重大影响。此外,该研究揭示了肌酐清除率增加与抗菌药物血药浓度之间呈负相关。本文全面综述了儿科患者ARC的筛查,包括其定义、危险因素和临床结局。此外,还总结了ARC儿科患者常用抗菌和抗病毒药物的剂量及给药方案,并针对剂量和输注注意事项以及治疗药物监测的作用提出了建议。

结论

ARC影响儿科患者的抗菌药物。

已知信息

• ARC与抗菌治疗失败、感染复发和药物亚治疗浓度密切相关。

新发现

• 本研究提供了ARC对儿科患者用药及临床结局影响的最新概述。• 在这种情况下,对于ARC儿科患者使用抗生素有以下几点建议:1)增加给药剂量;2)延长或持续输注给药;3)使用治疗药物监测;4)使用不经过肾脏消除的替代药物。

相似文献

1
Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.肾功能增强的儿科患者抗菌药物的个体化应用:文献综述
Eur J Pediatr. 2024 Jan;183(1):51-60. doi: 10.1007/s00431-023-05272-x. Epub 2023 Oct 20.
2
Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?儿科重症监护中的增强肾清除率:我们是否对病情最严重的患者治疗不足?
Pediatr Nephrol. 2020 Jan;35(1):25-39. doi: 10.1007/s00467-018-4120-2. Epub 2018 Oct 29.
3
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.危重症患者的增强肾脏清除率:系统评价。
Clin Pharmacokinet. 2018 Sep;57(9):1107-1121. doi: 10.1007/s40262-018-0636-7.
4
Are Antibiotics Appropriately Dosed in Critically Ill Patients with Augmented Renal Clearance? A Narrative Review.危重症合并肾脏清除增强患者的抗生素给药是否恰当?一项叙述性综述。
Int J Clin Pract. 2022 Jan 31;2022:1867674. doi: 10.1155/2022/1867674. eCollection 2022.
5
Scoping review of augmented renal clearance in critically ill pediatric patients.危重症儿科患者强化肾清除率的范围综述
Pharmacotherapy. 2021 Oct;41(10):851-863. doi: 10.1002/phar.2617. Epub 2021 Aug 30.
6
Augmented renal clearance: implications for antibacterial dosing in the critically ill.增强的肾功能清除:对危重症患者抗菌药物剂量的影响。
Clin Pharmacokinet. 2010;49(1):1-16. doi: 10.2165/11318140-000000000-00000.
7
Drug Utilization in Critically Ill Adults with Augmented Renal Clearance Compared to Normal Renal Clearance: Implications for use of Antimicrobials with Predominant Renal Excretion.增强肾清除率与正常肾清除率的危重病成人的药物利用:对主要经肾脏排泄的抗菌药物使用的影响。
Curr Rev Clin Exp Pharmacol. 2021;16(2):174-181. doi: 10.2174/1574884715666200810095225.
8
Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.肾功能增强对重症患者药物剂量的影响:聚焦于抗生素
Pharmacotherapy. 2015 Nov;35(11):1063-75. doi: 10.1002/phar.1653.
9
[Research advances in augmented renal clearance in critically ill children].[危重症儿童肾脏清除率增加的研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Oct;21(10):1055-1058. doi: 10.7499/j.issn.1008-8830.2019.10.019.
10
Augmented Renal Clearance.增强的肾脏清除率。
Pharmacotherapy. 2019 Mar;39(3):346-354. doi: 10.1002/phar.2231. Epub 2019 Mar 11.

引用本文的文献

1
Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid.新型 3,4-二羟基苯乙酸酰腙衍生物的设计、合成、分子对接研究及α-葡萄糖苷酶抑制活性评价。
Sci Rep. 2024 May 18;14(1):11410. doi: 10.1038/s41598-024-62034-x.

本文引用的文献

1
Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements.危重新生儿和儿童的肾小球滤过率:基于肌酐的估算与基于碘海醇的测量。
Pediatr Nephrol. 2023 Apr;38(4):1087-1097. doi: 10.1007/s00467-022-05651-w. Epub 2022 Aug 2.
2
Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study.在混合重症监护病房人群中与增强肾清除率相关的风险因素:一项回顾性研究。
Int J Clin Pharm. 2022 Dec;44(6):1277-1286. doi: 10.1007/s11096-022-01458-9. Epub 2022 Jul 14.
3
Association of Vancomycin Trough Concentration and Clearance With Febrile Neutropenia in Pediatric Patients.
儿科患者万古霉素谷浓度及清除率与发热性中性粒细胞减少症的相关性
Ther Drug Monit. 2022 Aug 1;44(4):543-551. doi: 10.1097/FTD.0000000000000978.
4
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis.喹诺酮类药物在儿童中的安全性:系统评价和荟萃分析。
Paediatr Drugs. 2022 Sep;24(5):447-464. doi: 10.1007/s40272-022-00513-2. Epub 2022 Jun 30.
5
Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients.静脉注射阿昔洛韦在儿科肿瘤患者中的群体药代动力学
Front Pharmacol. 2022 Apr 14;13:865871. doi: 10.3389/fphar.2022.865871. eCollection 2022.
6
Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome.危重症患儿β-内酰胺类药物治疗不充分:危险因素和结局。
Pediatr Crit Care Med. 2022 Jul 1;23(7):e309-e318. doi: 10.1097/PCC.0000000000002951. Epub 2022 Apr 15.
7
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!确保恶性肿瘤患儿广谱β-内酰胺类抗生素的谷浓度足够:谨防肾脏清除率增加!
Front Pediatr. 2022 Jan 5;9:768438. doi: 10.3389/fped.2021.768438. eCollection 2021.
8
Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study.增强肾清除率与危重症婴儿正常肾功能时万古霉素清除率的比较:一项群体药代动力学研究。
J Clin Pharmacol. 2022 Jul;62(7):863-872. doi: 10.1002/jcph.2029. Epub 2022 Feb 14.
9
Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.哌拉西林他唑巴坦持续输注可显著提高发热癌症儿童的目标达标率。
Cancer Rep (Hoboken). 2022 Oct;5(10):e1585. doi: 10.1002/cnr2.1585. Epub 2021 Nov 18.
10
Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations.儿童中性粒细胞减少伴发热患者增强肾清除率时万古霉素的群体药代动力学:新剂量推荐的制定。
J Antimicrob Chemother. 2021 Oct 11;76(11):2932-2940. doi: 10.1093/jac/dkab302.